How Alexithymia Can Stall Therapy Progress

Executive summary

Alexithymia refers to a clinically meaningful pattern of difficulty identifying feelings, difficulty describing feelings, and a more externally oriented (concrete) thinking style, often with constricted fantasy or imagery depending on the model and instrument used.[1][2][4] Clinically, alexithymia is not a formal DSM or ICD diagnosis; it is better understood as a transdiagnostic dimension that can co-occur with many presenting problems and quietly interfere with standard psychotherapy tasks such as emotion labeling, meaning-making, memory reconsolidation, mentalization, and alliance-building.[13][15]

Population studies commonly find roughly ~10% of adults meet high alexithymia thresholds when operationalized with TAS-20 cutoffs, with variation by age, gender, culture, and measurement approach.[23][2][3] Clinical prevalence is often higher and can be substantial in trauma-affected, psychosomatic or somatic-symptom, substance-use, eating-disorder, and chronic pain populations.[25][26][28]

The stall in therapy is rarely a matter of motivation alone. Evidence converges on several mechanisms: reduced emotional granularity and recognition, disrupted mentalization when emotional language is required, weaker alliance signals, emotion regulation patterns skewed toward avoidance or undifferentiated distress, and altered interoceptive access to bodily affect cues.[9][8][10][12] These mechanisms are plausible not only clinically but also neurocognitively, especially in PTSD populations where alexithymia can be distinct from emotion numbing.[20][27]

Across modalities, the outcome literature is mixed but clinically important: alexithymia has repeatedly been associated with poorer process and/or outcome in psychodynamic and supportive therapies, and in some contexts may impair response in CBT, IPT, or trauma treatment through process variables like therapist reactions, alliance, and emotional engagement.[13][14][16][19] At the same time, alexithymia is modifiable to a meaningful degree. A recent meta-analysis found an overall medium reduction in alexithymia relative to control, with stronger average effects in integrative and CBT or third-wave packages.[29]

For therapists, the practical implication is hopeful: screen early, treat alexithymia as a treatment-interfering process rather than a difficult patient trait, and use measured, skills-forward adaptations such as psychoeducation, labeling scaffolds, mentalization supports, interoceptive training, pacing, experiential methods, and measurement-based care.[13][19][29]

Conceptual overview and prevalence

What alexithymia is

The term was introduced in psychosomatic psychotherapy contexts to describe patients who struggled to work within insight-oriented, affect-focused approaches, characterized by limited emotional language, constrained imaginative processes, and a tendency toward concrete, externally focused discourse. Contemporary measurement commonly operationalizes alexithymia via three core features.[1][2][3]

• Difficulty Identifying Feelings (DIF)
• Difficulty Describing Feelings (DDF)
• Externally Oriented Thinking (EOT)[1][2][3]

Some models and instruments add fantasizing or imaginal processes and emotionalizing facets, aiming to capture a broader profile than the TAS-20 alone.[4][5]

How common it is

Large community studies frequently report prevalence around ~10% when using conventional TAS-20 high alexithymia thresholds, though estimates vary by population and instrument.[23][2][3] In Deborde and colleagues' work, the authors summarize alexithymia prevalence as around ~15% in the normal population while emphasizing that clinical samples can show much higher rates.[5]

In several clinical domains that commonly present to psychotherapy:

• PTSD: meta-analytic work has consistently found elevated alexithymia in PTSD, with newer syntheses reporting very high pooled prevalence estimates while noting heterogeneity.[28][27]
• Somatization / somatic symptom reporting: quantitative review findings suggest a small-to-moderate association between alexithymia and somatic symptom reporting.[25]
• Chronic pain: alexithymia is elevated in chronic pain and is associated with pain-related outcomes and internalizing symptoms.[26]
• Autism spectrum: alexithymia is common in autistic samples and may explain some emotion-processing findings historically attributed to autism itself.[24]

Trait-state considerations

Alexithymia shows meaningful relative stability, but it can also shift with changes in distress, depression, and treatment exposure, suggesting it can be trait-like while still being clinically modifiable. This matters in therapy: when alexithymia decreases alongside symptom relief, that change may reflect improved emotional processing, reduced general distress that previously inflated self-report scores, or both.[21][22]

Assessment and screening in clinical practice

Validated tools and practical cutoffs

Because alexithymia is best conceptualized as a dimension rather than a categorical diagnosis, self-report measures are most useful for clarifying where the difficulty is showing up and for tracking change over time, not for making a stand-alone diagnosis. In the current measurement landscape, TAS-20 remains the older benchmark in much of the psychotherapy literature, while PAQ-24 offers a newer and more detailed profile of difficulty identifying feelings, difficulty describing feelings, and externally oriented thinking across both negative and positive emotions.[15][22][30][31][32]

Table of assessment tools

Clinical takeaway: TAS-20 still matters because much of the historical psychotherapy literature uses it. But for clinicians who want a fuller assessment of alexithymia, PAQ-24 offers a richer, more detailed profile of how difficulties show up across identifying, describing, and attending to emotions, including differences between negative and positive affect.[6][7][31][35]

Brief screening cues and micro-probes you can use in session

Therapists often miss alexithymia because the presentation can look like flat affect, avoidance, treatment resistance, or intellectualizing. The difference is that alexithymia is frequently an ability or processing bottleneck rather than a choice.[13][9][5]

Common clinical cues, especially when repeated across sessions:

• The client can describe events and thoughts in detail but struggles to answer "What did you feel?" or defaults quickly to "I don't know," "fine," "stressed," or "numb."[2][9]
• Affect vocabulary is narrow, with limited differentiation.[9][22]
• The client reports bodily symptoms or arousal but cannot map them to emotion.[11][10][25]
• Homework that requires emotion monitoring, imagery, or narrative meaning-making feels confusing or pointless despite genuine effort.[13][19]

Brief in-session probes, keeping the tone curious and non-shaming:

• "If your body could pick one word for what's happening right now - tension, heaviness, heat, buzzing, sinking - which fits best?"[10][11]
• "When you say 'stressed,' is that closer to worried, sad, angry, or overwhelmed, or none of those?"[9][2]
• "If we put feelings aside for a moment, what did you want in that moment? What felt threatened or important?"[9][5]
• "If a friend saw you then, what might they guess you were feeling?"[6]

Differential signs: alexithymia vs depression, autism spectrum, psychopathy-related presentations

This differential is not about exclusion; it is about what to target first so therapy can move.

Versus depression: Depression can reduce energy, interest, and emotional responsivity, but alexithymia is specifically about recognizing, labeling, and verbalizing emotion. Some research suggests TAS-20 scores can shift with depression severity, while other work supports meaningful relative stability even when depressive symptoms improve.[21][22]

Versus autism spectrum-related emotion difficulties: alexithymia is common in autistic samples and may account for some emotion-recognition findings previously assumed to be core autism features.[24] Clinically, ASD-related challenges often include broader social-communication differences and developmental history, while alexithymia-focused work targets emotional self-awareness and labeling.[24]

Versus psychopathy / callous traits presentations: a key distinction is between difficulty accessing and labeling internal states and diminished concern or affective empathy with relatively intact cognitive description. Empirical work is more limited here, but therapy targets and risk management differ substantially.[8]

How alexithymia impairs therapy mechanisms of change

Therapy progress typically requires some combination of emotional awareness, cognitive-affective integration, interpersonal learning, and regulation flexibility. Alexithymia can interfere at multiple points.

Emotion recognition and emotional granularity

Alexithymia is associated with poorer facial expression recognition performance, and broader reviews tie it to reduced emotion recognition and empathy-related processes.[12][8] In the therapy room, this often looks like:

• "I know something's happening, but I can't tell what."
• a default to global labels like "bad" or "stressed"
• difficulty linking triggers -> emotion -> meaning -> action tendency

This matters because many modalities assume at least minimal access to emotion labeling.[13][19]

Mentalization and reflective functioning

Mentalization tasks can be selectively difficult when the task relies on emotion recognition. Associations are mixed overall, but deficits are more apparent when theory-of-mind tasks involve emotional content.[8] In therapy, this can stall meaning-making, relational understanding, and rupture repair.

Therapeutic alliance and therapist reactions

Alexithymia can strain alliance indirectly, not necessarily because the client does not care, but because the usual interpersonal signals may be weaker or less legible. Programmatic psychotherapy work points to therapist-related pathways, and group therapy studies suggest therapist reactions mediate part of the alexithymia-outcome link.[13][14]

In depression treatment trials, alexithymia has also been linked to alliance and outcome dynamics across CBT and IPT contexts.[16]

Emotion regulation patterns that reduce therapeutic dose

Alexithymia is associated with a less adaptive emotion regulation profile.[9] Clinically, this can blunt mechanisms of exposure, emotional processing, and corrective emotional experience by pushing therapy toward:

• cognitive problem-solving without emotional updating
• avoidance of affect engagement
• somatic focus without emotional integration[25][9]

Interoception and body-emotion mapping

Interoception is a promising but complex pathway. Theoretical work proposes alexithymia reflects, in part, a deficit in perceiving or interpreting internal bodily signals that contribute to emotion experience.[11] Empirical work is mixed, but current meta-analytic findings still support the practical bridge strategy: start with sensations and gradually build toward emotion labels and narratives.[10]

Neurobiological correlates relevant to therapy

In PTSD samples, alexithymia and PTSD-related emotional numbing can show partially distinct neural correlates, suggesting alexithymia is not simply another word for numbing.[20] This matters clinically because trauma-focused methods often require safe emotional engagement; if alexithymia rather than numbing is the main difficulty, the adaptation may need to prioritize emotional awareness scaffolding before, or alongside, intensive exposure work.[19][27]

Evidence linking alexithymia to poorer therapy outcomes and processes

What the psychotherapy outcome literature suggests

A programmatic review concluded that across studies, alexithymia is more often associated with poorer psychotherapy outcome than with no effect, with particularly consistent negative findings in psychodynamic and supportive therapies.[13] However, findings are not uniform, and some CBT studies report minimal or no negative impact, suggesting moderation by disorder, treatment format, and whether the therapy directly targets emotional awareness.[13]

A later systematic review across psychiatric disorders similarly emphasizes a complex, heterogeneous role for alexithymia in predicting response to psychotherapeutic and pharmacologic interventions.[15]

Outcome studies by modality and clinical context

The table below samples higher-citation, clinically relevant studies that therapists commonly translate into practice. It is intentionally selective rather than exhaustive.

Links with comorbidity that can complicate therapy

Comorbidity matters because alexithymia can shape symptom presentation, which in turn influences case formulation and treatment targets.

• Depression severity: alexithymia total scores correlate positively with depression severity, with DIF and DDF often more strongly linked than EOT.[15]
• PTSD: PTSD is associated with higher alexithymia and clinically meaningful between-group differences.[28][27]
• Somatic symptom reporting: small-to-moderate associations are common, though interpretation must remain cautious because somatization is defined differently across studies.[25]
• Chronic pain: alexithymia is elevated in chronic pain and relates to internalizing symptoms and functioning.[26]
• Dissociation: strong associations matter clinically in trauma treatment planning.[18]

Intervention strategies and adaptations

What the intervention evidence says about changing alexithymia

A 2026 systematic review and meta-analysis estimated that psychological interventions reduce alexithymia compared with control conditions, with a medium average effect.[29] Subgroup analyses suggested larger average effects for integrative and CBT / third-wave interventions, while several categories showed substantial heterogeneity.[29]

This is encouraging for clinicians: alexithymia is not a fixed barrier, but its improvement may require explicit targeting and adequate dosing and pacing.

Table of interventions and practical clinical deployment

Evidence levels are summarized pragmatically as stronger, emerging, or clinical rationale. The resource column reflects typical training and time needs in outpatient therapy.

Session-level tips and brief scripts

Pacing principle: treat emotional awareness like graded exposure. Too much too soon can produce shutdown, while tiny repeated reps create more reliable gains.[5][9][13]

Micro-script: normalizing and collaborating

Micro-script: sensation-to-emotion bridge

Micro-script: forced-choice without infantilizing

Micro-script: alliance safeguard

Interpreting the meta-analytic effect-size chart

The chart above summarizes subgroup effects from the 2026 meta-analysis. Two clinically relevant cautions:

• Wide confidence intervals in some categories suggest heterogeneity and limited precision for certain intervention families.[29]
• Integrative and CBT / third-wave interventions show stronger average reductions, but that does not mean other modalities cannot work; it suggests that explicit skills plus structured emotional practice may be particularly helpful.[29][13]

Training, supervision, and implementation workflow

Training and supervision recommendations

Because alexithymia can evoke therapist frustration or premature interpretive leaps, supervision is often the place it becomes visible. Programmatic psychotherapy research highlights therapist reactions as one plausible pathway linking alexithymia to poorer outcomes, especially in relational and group contexts.[14][13]

High-yield supervision targets:

• Case conceptualization: explicitly name alexithymia as a mechanism-level target rather than as resistance.[13][9]
• Alliance skill: train therapists to ask permission, check fit, and use non-shaming language when emotions are unclear.[16][14]
• Competency building: practice brief emotion-label scaffolds, interoceptive bridging, and mentalization prompts in role-play.[7][10][8]
• Measurement literacy: supervise to outcome dashboards and adapt plan when alexithymia remains high and progress stalls.[29][3]

Suggested assessment-to-intervention workflow

Intake or early sessions
  ↓
Cues of difficulty accessing emotion?
  ├─ No  → Proceed with standard formulation + routine outcomes tracking
  └─ Yes → Screen: PAQ-24 or BVAQ (baseline)
             ↓
      High or borderline scores OR strong clinical suspicion?
        ├─ No  → Monitor; re-screen if progress stalls
        └─ Yes → Clarify drivers: depression severity, trauma load,
                  ASD traits, dissociation, pain / somatic focus
                    ↓
             Self-report seems unreliable or case remains stuck?
               ├─ Yes → Add TSIA and/or observer measure (OAS)
               │         + performance-based tasks if available
               └─ No  → Proceed with alexithymia-informed case plan
                            ↓
                     Phase 1: Psychoeducation + emotion-label scaffolding
                              + sensation-to-emotion bridging
                            ↓
                     Phase 2: Regulation skills + graded experiential work
                            ↓
                     Phase 3: Meaning-making / relational work
                              (mentalization supports, alliance repair)
                            ↓
                     Measurement-based care:
                     repeat PAQ-24 + symptom scales over time
                            ↓
                     Adequate progress?
                       ├─ Yes → Consolidate skills + relapse prevention
                       └─ No  → Adjust pacing, modality mix, dose,
                                 consult / supervision, add comorbidity-focused work

One-page clinician checklist

Alexithymia-aware therapy checklist

Screen / detect

• I watch for repeated "I don't know what I feel" patterns, narrow emotion vocabulary, and concrete or external-only narratives.[2][5]
• I administer PAQ-24 early when emotional work is central or progress is slow.[30][31][35]
• If needed, I add BVAQ or TSIA / OAS to reduce self-report bias.[5][7][6]

Interpret thoughtfully

• I interpret scores dimensionally and consider distress-related validity concerns or state effects.[21][22][36]
• I consider comorbid PTSD, dissociation, chronic pain, and somatic symptom reporting as common funnels for alexithymia.[27][18][26][25]

Adapt treatment

• I start with psychoeducation: emotion recognition is a trainable skill.[19][29]
• Each session includes a brief sensation -> emotion label -> need/value -> action sequence.[10][9][11]
• I offer emotion words as choices, not as a test, and treat labels as hypotheses.[9][2]
• I pace experiential work and build readiness rather than forcing deep processing.[19][27]

Protect alliance

• I explicitly check the fit of my reflections and normalize confusion about feelings.[16][14]
• I monitor my own frustration or "nothing is happening" reactions and bring them to supervision.[14][13]

Measure and recalibrate

• I repeat PAQ-24 alongside symptom measures when I want to track alexithymia over time.[34][35]
• If alexithymia remains high and outcomes plateau, I adjust with more scaffolding, slower pacing, more structure, additional methods, or consultation.[13][29]

Gaps, limitations, and research / practice recommendations

Key limitations in the evidence base:

• Measurement challenges: self-report measures require insight into one's own emotional deficits; content-validity critiques and distress-related validity debates remain active.[22][21][6][15][36]
• Heterogeneity of outcome findings: across diagnoses and modalities, effects vary and many studies are naturalistic or underpowered for moderators.[15][13][29]
• Mechanism specificity: interoception findings depend on what component is measured, and theory-of-mind deficits appear more consistent when emotional recognition is required.[10][8][12]

Practical recommendations that follow from current evidence:

• Build alexithymia screening into early case formulation when therapy relies on emotional processing.[13][27][19]
• Treat alexithymia as a measurable treatment-interfering process with explicit skills targets and measurement-based care loops.[29]
• Prioritize future research on mechanism-focused adaptations, multi-method assessment, and moderators such as diagnosis, trauma load, autism traits, dissociation, and chronic pain.[15][26]